
- Telehealth Visits
- Insurance plan information

Kanika Bhardwaj, MD
Medical Genetics- Telehealth Visits
- Insurance plan information



Kanika Bhardwaj, MD
Medical Genetics- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Kanika Bhardwaj is a medical geneticist who cares for patients with genetic diseases, including cancers and conditions affecting the heart or brain. She is dedicated to providing compassionate care for all.
Bhardwaj's research focuses on understanding and treating genetic conditions that emerge or worsen in adulthood. Her areas of investigation include the genetics of late-onset diseases, the role that genetic variation plays in disease risk and outcomes, and personalized approaches to care based on genetic information.
Bhardwaj earned her medical degree at the Armed Forces Medical College in India. She completed a residency in internal medicine at Nuvance Health and a fellowship in medical genetics and genomics at the University of California, San Diego.
Outside the clinic, Bhardwaj is passionate about baking, exploring the great outdoors and traveling to new places. Each adventure brings her joy and inspiration, and she loves sharing these experiences with others.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Fellowship
- University of California - San Diego
Residency
- Internal Medicine, Nuvance Health
Degree
- Armed Forces Medical College
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225502%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225502%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.